sign101

56. Abu-Hasan M, Tannous B, Weinberger M. Exercise-induced dyspnea in
children and adolescents: if not asthma then what? Ann Allergy Asthma
Immunol. 2005;94(3):366-71.
57. Lex C, Payne DN, Zacharasiewicz A, Li AM, Wilson NM, Hansel TT, et
al. Sputum induction in children with difficult asthma: safety, feasibility,
and inflammatory cell pattern. Pediatr Pulmonol. 2005;39(4):318-24.
58. Rytila P, Pelkonen AS, Metso T, Nikander K, Haahtela T, Turpeinen
M. Induced sputum in children with newly diagnosed mild asthma:
The effect of 6 months of treatment with budesonide or disodium
cromoglycate. Allergy 2004;59(8):839-44.
59. Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J,
et al. Safety and application of induced sputum analysis in childhood
asthma. J Allergy Clin Immunol. 2004;114(3):575-82.
60. Malmberg LP, Turpeinen H, Rytila P, Sarna S, Haahtela T. Determinants
of increased exhaled nitric oxide in patients with suspected asthma.
Allergy 2005;60(4):464-8.
61. Brussee JE, Smit HA, Kerkhof M, Koopman LP, Wijga AH, Postma DS, et
al. Exhaled nitric oxide in 4-year-old children: relationship with asthma
and atopy. Eur Respir J. 2005;25(3):455-61.
62. Barreto M, villa MP, Monti F, Bohmerova Z, Martella S, Montesano M,
et al. Additive effect of eosinophilia and atopy on exhaled nitric oxide
levels in children with or without a history of respiratory symptoms.
Pediatr Allergy Immunol. 2005;16(1):52-8.
63. Malmberg LP, Petays T, Haahtela T, Laatikainen T, Jousilahti P,
vartiainen E, et al. Exhaled nitric oxide in healthy nonatopic school-age
children: Determinants and height-adjusted reference values. Pediatr
Pulmonol. 2006;41(7):635-42.
64. Prasad A, Langford B, Stradling JR, Ho LP. Exhaled nitric oxide
as a screening tool for asthma in school children. Respir Med.
2006;100(1):167-73.
65. Pijnenburg MW, Floor SE, Hop WC, De Jongste JC. Daily ambulatory
exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol.
2006;17(3):189-93.
66. Chan EY, Dundas I, Bridge PD, Healy MJ, McKenzie SA. Skin-prick
testing as a diagnostic aid for childhood asthma. Pediatr Pulmonol.
2005;39(6):558-62.
67. Eysink PE, ter Riet G, Aalberse RC, van Aalderen WM, Roos CM, van
der Zee JS, et al. Accuracy of specific IgE in the prediction of asthma:
development of a scoring formula for general practice. Br J Gen Pract.
2005;55(511):125-31.
68. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A,
Custovic A. IgE antibody quantification and the probability of wheeze
in preschool children. J Allergy Clin Immunol. 2005;116(4):744-9.
69. Kurukulaaratchy RJ, Fenn M, Matthews S, Arshad SH. Characterisation
of atopic and non-atopic wheeze in 10 year old children. Thorax
2004;59(7):563-8.
70. Hederos CA, Janson S, Andersson H, Hedlin G. Chest x-ray investigation
in newly discovered asthma. Pediatr Allergy Immunol 2004;15(2):163-
5.
71. Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID. A
comparison of the validity of different diagnostic tests in adults with
asthma. Chest 2002;121(4):1051-7.
72. Joyce DP, Chapman KR, Kesten S. Prior diagnosis and treatment of
patients with normal results of methacholine challenge and unexplained
respiratory symptoms. Chest 1996;109(3):697-701.
73. Brand PL, Postma DS, Kerstjens HA, Koeter GH. Relationship of airway
hyperresponsiveness to respiratory symptoms and diurnal peak flow
variation in patients with obstructive lung disease. The Dutch CNSLD
Study Group. Am Rev Respir Dis 1991;143(5 Pt 1):916-21.
74. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical
manifestations and implications for treatment. Thorax 2002;57(2):178-
82.
75. James AL, Finucane KE, Ryan G, Musk AW. Bronchial responsiveness,
lung mechanics, gas transfer, and corticosteroid response in patients
with chronic airflow obstruction. Thorax 1988;43(11):916-22.
76. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial
responsiveness to methacholine in chronic bronchitis: relationship to
airflow obstruction and cold air responsiveness. Thorax 1984;39(12):912-
8.
77. Goldstein MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA,
Haralabatos IC. Comparisons of peak diurnal expiratory flow
variation, postbronchodilator FEv(1) responses, and methacholine
inhalation challenges in the evaluation of suspected asthma. Chest
2001;119(4):1001-10.
78. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-
Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response.
Am J Respir Crit Care Med. 2005;172(4):453-9. .
79. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson
P, et al. Diagnosing asthma: comparisons between exhaled nitric oxide
measurements and conventional tests. Am J Respir Crit Care Med.
2004;169(4):473-8. (34 ref).
80. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric
oxide measurements: clinical application and interpretation. Thorax
2006;61(9):817-27.
referenCes
81. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw
AJ, et al. Sputum eosinophilia and short-term response to prednisolone
in chronic obstructive pulmonary disease: a randomised controlled trial.
Lancet 2000;356(9240):1480-5.
82. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, et
al. Exhaled nitric oxide as a noninvasive assessment of chronic cough.
Am J Respir Crit Care Med 1999;159(6):1810-3.
83. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic
corticosteroid unresponsive asthma. Lancet 1999;353(9171):2213-4.
84. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding
P, et al. Asthma exacerbations and sputum eosinophil counts: a
randomised controlled trial. Lancet 2002;360(9347):1715-21.
85. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use
of exhaled nitric oxide measurements to guide treatment in chronic
asthma. N Engl J Med 2005;352(21):2163-73.
86. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E,
et al. Determining asthma treatment by monitoring sputum cell counts:
Effect on exacerbations. Eur Respir J. 2006;27(3):483-94.
87. Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, et al.
Alveolar nitric oxide in adults with asthma: evidence of distal lung
inflammation in refractory asthma. Eur Respir J 2005;25(6):986-91.
88. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak
expiratory flow: conclusion and recommendations of a working party of
the European Respiratory Society. Eur Respir J Suppl. 1997;24:2S-8S.
89. D‘Alonzo GE, Steinijans VW, Keller A. Measurements of morning and
evening airflow grossly underestimate the circadian variability of FEV1
and peak expiratory flow rate in asthma. Am J Respir Crit Care Med
1995;152(3):1097-9.
90. Chowienczyk PJ, Parkin DH, Lawson CP, Cochrane GM. Do asthmatic
patients correctly record home spirometry measurements? BMJ
1994;309(6969):1618.
91. Higgins BG, Britton JR, Chinn S, Jones TD, Jenkinson D, Burney PG,
et al. The distribution of peak flow variability in a population sample.
Am Rev Respir Dis 1989;140(5):1368-72.
92. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PG, Tattersfield
AE. Comparison of bronchial reactivity and peak expiratory flow
variability measurements for epidemiologic studies. Am Rev Respir
Dis 1992;145(3):588-93.
93. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of
diurnal changes in peak expiratory flow rates. Relationship to symptoms
and respiratory disease. Am Rev Respir Dis 1991;143(2):323-30.
94. Lebowitz MD, Krzyzanowski M, Quackenboss JJ, O‘Rourke MK. Diurnal
variation of PEF and its use in epidemiological studies. Eur Respir J
Suppl. 1997(24):49s-56s.
95. Boezen HM, Schouten JP, Postma DS, Rijcken B. Distribution of peak
expiratory flow variability by age, gender and smoking habits in a random
population sample aged 20-70 yrs. Eur Respir J 1994;7(10):1814-20.
96. Siersted HC, Hansen HS, Hansen NC, Hyldebrandt N, Mostgaard G,
Oxhoj H. Evaluation of peak expiratory flow variability in an adolescent
population sample. The Odense Schoolchild Study. Am J Respir Crit
Care Med 1994;149(3 Pt 1):598-603.
97. Gannon PF, Newton DT, Belcher J, Pantin CF, Burge PS. Development
of OASyS-2: a system for the analysis of serial measurement of peak
expiratory flow in workers with suspected occupational asthma. Thorax
1996;51(5):484-9.
98. Crapo R. Guidelines for methacholine and exercise challenge testing-
1999. Am J Respir Crit Care Med 2000;161(1):309-29.
99. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity
to inhaled histamine: a method and clinical survey. Clin Allergy
1977;7(3):235-43.
100. Cockcroft DW, Murdock Ky, Berscheid BA, Gore BP. Sensitivity and
specificity of histamine PC20 determination in a random selection of
young college students. J Allergy Clin Immunol 1992;89(1 Pt 1):23-
30.
101. Joos GF, O‘Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen
B, et al. Indirect airway challenges. Eur Respir J 2003;21(6):1050-68.
102. Anderton RC, Cuff MT, Frith PA, Cockcroft DW, Morse JL, Jones NL,
et al. Bronchial responsiveness to inhaled histamine and exercise. J
Allergy Clin Immunol 1979;63(5):315-20.
103. American Thoracic Society, European Respiratory Society. ATS/ERS
recommendations for standardized procedures for the online and offline
measurement of exhaled lower respiratory nitric oxide and nasal nitric
oxide. Am J Respir Crit Care Med 2005;171(8):912-30.
104. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use
of induced sputum to investigate airway inflammation. Thorax
1997;52(6):498-501.
105. Brightling CE, Pavord ID. Eosinophilic bronchitis: an important cause
of prolonged cough. Ann Med 2000;32(7):446-51.
106. Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley
MJ. A systematic evaluation of mechanisms in chronic cough. Am J
Respir Crit Care Med 1997;156(1):211-6.
107. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels
RA, et al. Can guideline-defined asthma control be achieved? The
Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med
2004;170(8):836-44.
127